Inflammatory myopathy: treatment
Evidence-based neurology checklist on inflammatory myopathy: treatment: Acute treatment Prednisolone Intravenous immunoglobulins (IVIg): indications Long-term treatment Treatment of refractory cases JAK inhibitors: indications JAK inhibitors: types
Acute treatment
- Prednisolone
- Intravenous immunoglobulins (IVIg): indications
Long-term treatment
Treatment of refractory cases
JAK inhibitors: indications
JAK inhibitors: types
References
- Dalakas MC. Therapeutic advances and future prospects in immune-mediated inflammatory myopathies. Ther Adv Neurol Disord 2008; 1:157-166.
- Gandiga PC, Ghetie D, Anderson E, Aggrawal R. Intravenous immunoglobulin in idiopathic inflammatory myopathies: a practical guide for clinical use. Curr Rheumatol Rep 2023; 25:152-168.
- Rietveld A, Lim J, de Visser M, et al. Autoantibody testing in idiopathic inflammatory myopathies. Pract Neurol 2019; 19:284-294.
- Mahler EAM, Blom M, Voermans NC, van Engelen BGM, van Riel PLCM, Vonk MC. Rituximab treatment in patients with refractory inflammatory myopathies. Rheumatology 2011; 50:2206-2213.
- Sabbagh S, Almeida de Jesus A, et al. Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib. Brain 2019; 142:e59.
- And 4 more. Subscribe to see the full list
